We are live on ! Find out more
VF

Virtu Financial Portfolio holdings

AUM $3.18B Turnover 77.45%
1-Year Est. Return 65.92%
This Fund
S&P 500
This Quarter Est. Return
+9.13%
1 Year Est. Return
+65.92%
3 Year Est. Return
+160.27%
5 Year Est. Return
+179.96%
10 Year Est. Return
–
AUM
$1.03B
AUM Growth
-$383M
Cap. Flow
-$421M
Cap. Flow %
-40.89%
Top 10 Hldgs %
24.29%
Holding
2,439
New
893
Increased
252
Reduced
276
Closed
992
Avg Time Held
0.2 years
Top 10 Avg Time Held
0.1 years
Top 20 Avg Time Held
0.1 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 21.76%
2 Healthcare 21.62%
3 Technology 11.02%
4 Consumer Discretionary 9.41%
5 Communication Services 9.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
UXIN icon
2101
Uxin Ltd
UXIN
$222M
– –
-209
Closed -$24K –
V icon
2102
Visa
V
$756B
– –
-9,653
Closed -$2.04M –
VATE icon
2103
INNOVATE Corp
VATE
$81.9M
– –
-3,082
Closed -$121K –
VCYT icon
2104
Veracyte
VCYT
$3.47B
– –
-12,512
Closed -$673K –
VEON icon
2105
VEON
VEON
$5.73B
– –
-598
Closed -$26K –
VERO icon
2106
DELISTED
Venus Concept
VERO
– –
-91
Closed -$35K –
VIAV icon
2107
Viavi Solutions
VIAV
$8.21B
– –
-16,208
Closed -$254K –
VIST icon
2108
Vista Energy
VIST
$7.96B
– –
-19,355
Closed -$50K –
VIV icon
2109
Telefônica Brasil
VIV
$20B
– –
-26,541
Closed -$209K –
VMC icon
2110
Vulcan Materials
VMC
$33.4B
– –
-5,841
Closed -$986K –
VMI icon
2111
Valmont Industries
VMI
$8.58B
– –
-1,710
Closed -$406K –
VNDA icon
2112
Vanda Pharmaceuticals
VNDA
$244M
– –
-10,142
Closed -$152K –
VNET icon
2113
VNET Group
VNET
$1.12B
– –
-10,621
Closed -$343K –
VNOM icon
2114
Viper Energy
VNOM
$8.75B
– –
-13,623
Closed -$198K –
VNT icon
2115
Vontier
VNT
$4.51B
– –
-17,598
Closed -$533K –
VOT icon
2116
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$18.9B
– –
-1,161
Closed -$249K –
VRCA icon
2117
Verrica Pharmaceuticals
VRCA
$61.8M
– –
-1,020
Closed -$155K –
VRNS icon
2118
Varonis Systems
VRNS
$5.6B
– –
-6,335
Closed -$325K –
VST icon
2119
Vistra
VST
$51B
– –
-12,237
Closed -$216K –
VTGN icon
2120
VistaGen Therapeutics
VTGN
$8.88M
– –
-2,071
Closed -$132K –
VTLE icon
2121
DELISTED
Vital Energy
VTLE
– –
-7,481
Closed -$225K –
VTR icon
2122
Ventas
VTR
$44B
– –
-30,706
Closed -$1.64M –
VWOB icon
2123
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.15B
– –
-4,451
Closed -$345K –
YARW
2124
Yarrow Bioscience
YARW
$155M
– –
-15
Closed -$93K –
W icon
2125
Wayfair
W
$14.7B
– –
-976
Closed -$307K –

Similar funds

Virtu Financial's Q2 2021 Portfolio in Review

As of Q2 2021, Virtu Financial held 2,439 positions worth $1.03B, down 27% from $1.41B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Virtu Financial withdrew a net $421M in Q2 2021, closing 992 positions and reducing 276 holdings. Its most notable exit was SPDR Gold Trust, an estimated $213M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, down from 34% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Virtu Financial opened a new position in PRA Health Sciences, Inc. worth $111M.

  • Virtu Financial's largest Q2 2021 buy was PRA Health Sciences, Inc.: 668,921 shares worth $111M.
  • Virtu Financial added most to Alphabet (Google) Class A in Q2 2021, an estimated $16.1M increase.
  • Virtu Financial's biggest Q2 2021 reduction was Berkshire Hathaway Class B, cutting an estimated $56.6M.
  • Virtu Financial fully exited SPDR Gold Trust in Q2 2021, selling an estimated $213M.
  • Virtu Financial's ten largest holdings make up 24% of its $1.03B portfolio in Q2 2021.
  • Virtu Financial opened 893 new positions and closed 992 in Q2 2021.
  • Virtu Financial's portfolio value fell 27% quarter-over-quarter to $1.03B.

Based on Virtu Financial's 13F filing for Q2 2021, filed 17 Sep 2021.